跳至主要内容
临床试验/jRCT2031250138
jRCT2031250138尚未招募不适用

Phase 3 Clinical Study of JTE-061 Cream - 52-week Long-term Study in Infant Patients with Atopic Dermatitis -

Japan Tobacco Inc.0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
3month old over 至 24month old not(—)
性别
All

入选标准

  • Japanese patients aged 3 months to < 24 months at informed consent who can visit the study site as an outpatient
  • Patients with clinical diagnosis of AD according to the criteria of the Japanese Dermatological Association prior to or at informed consent
  • Patients whose IGA score, EASI score, and %BSA affected meet the criteria specified in the study protocol

排除标准

  • Patients with a current significant skin or inflammatory condition that, in the opinion of the investigator or subinvestigator, would make it difficult to interpret data or assessments during the study
  • Patients with a history of or current acute active bacterial, fungal, or viral (e.g., herpes simplex, herpes zoster, and varicella) skin infection within 1 week prior to Week 0
  • Patients who have used any prohibited therapy specified in the study protocol within the indicated period before Week 0
  • Patients with serious concomitant disease(s)
  • Patients with a history or current cancer

结局指标

主要结局

-

Proportion of subjects with >= 75% improvement in EASI score from Baseline at Week 8

次要结局

未报告次要终点

研究者

相似试验